MedPath

Acupuncture for Antenatal Depression.

Not Applicable
Completed
Conditions
Antenatal Depression
Alternative and Complementary Medicine - Other alternative and complementary medicine
Mental Health - Depression
Reproductive Health and Childbirth - Antenatal care
Registration Number
ACTRN12615000250538
Lead Sponsor
Western Sydney University - National Institute of Complementary Medicine
Brief Summary

Antenatal depression is common, with wide-ranging detrimental consequences. Despite this, symptomologies are frequently inadequately managed. Consequently, women seek out alternatives. Preliminary evidence suggests acupuncture may provide a safe and potentially effective adjunct treatment. This study further examined this possibility. In this RCT, fifty-seven women meeting Edinburgh Postnatal Depression Scale (EPDS) scores greater than or equal to 13 were randomised to either individually tailored, depression specific acupuncture, progressive muscle relaxation (PMR) comparator, or treatment as usual. Women were also interviewed regarding their experiences of receiving acupuncture. Focus groups were in addition conducted with midwives to ascertain their views of the study. Findings demonstrated significantly reduced end of the intervention EPDS, stress component of the Depression, Stress and Anxiety scale, and Kessler 6 scores in the acupuncture group, when compared to the PMR and treatment as usual control groups. Mean cortisol: DHEA ratios were in addition significantly increased in the acupuncture group when compared to treatment as usual. Interviews confirmed acupuncture recipients perceived benefits. Midwives also reported receiving positive feedback from participants regarding benefits, as well as observing the improved disposition of recipients. Findings suggest acupuncture reduced or buffered stress, increased coping, and improved psychological well-being.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
57
Inclusion Criteria

Pregnant women will be eligible if they are: 18 years of age or older, at 24 weeks of gestation, currently experiencing a mood disorder and have a Edinburgh Postnatal Depression Scale (EPDS) scores of greater than or equal to 13.

Exclusion Criteria

Women experiencing: a major depressive episode more than 2 years duration; psychotic or manic features rendering them incapable of consent; post-traumatic stress disorder and phobia to needles; a current psychiatric assessment of suicidal risk; a condition necessitating bed rest; bleeding disorders and or other major obstetric risks will be excluded; as will those receiving acupuncture or PMR outside of the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The severity of depression as measured by the Edinburgh Postnatal Depression Scale (EPDS) .[Eligibility screening, intervention baseline (week 0), mid intervention (week 4), end of intervention (week 8) and at 6 weeks postnatal.];The duration of depression as measured by the EPDS[Baseline, mid (week 4), end of intervention (week 8) and at 6 weeks postnatal.]
Secondary Outcome Measures
NameTimeMethod
Depression, Stress and Anxiety (DASS)[Intervention commencement (week 0), mid intervention (week 4), end of intervention (week 8) and 6 weeks postnatal.];Quality of life - World Health Organisation Quality of Life Scale (WHOQoL-26).[Intervention commencement (week 0), mid intervention (week 4), end of intervention (week 8) and 6 weeks postnatal.];Adjustment to mothering - Being a Mother (BaM-13 Scale)[6 weeks postnatal];Salivary oxytocin[Baseline (week 0), mid intervention (week 4) and end of intervention (week 8).];Leukocyte oxytocin receptor mRNA expression[Baseline (week 0) and end of intervention (week 8)];Salivary cortisol[Baseline (week 0), mid intervention (week 4) and end of intervention (week 8).];Salivary DHEA[Baseline (week 0), mid intervention (week 4) and end of intervention (week 8).]
© Copyright 2025. All Rights Reserved by MedPath